<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2014092319272N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2015-03-24</date_registration>
      <primary_sponsor>University of Isfahan, Faculty of Physical Education &amp; Sport Science</primary_sponsor>
      <public_title>Home-based exercise rehabilitation and centre-based cardiac rehabilitation</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of home-based exercise rehabilitation with centre-based cardiac rehabilitation on lipid parameters, hematology and some behavioral indicators with coronary artery disease</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2013-11-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/17281</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research.</study_design>
      <phase>N/A</phase>
      <hc_freetext>coronary artery disease.</hc_freetext>
      <i_freetext>Intervention 1: Home-based exercise rehabilitation group: The subjects in this group participated in aerobic and resistance exercise at home for 8 weeks, 3 sessions per week about 60-90 minutes. The Home-based exercise program includes 10 min warm up, 5 min aerobic exercise, 5 min resistance exercise, 25–60 min brisk walking or jogging at an intensity of 11–13 on the Borg scale and 10 min cool down. Intervention 2: Centre-based cardiac rehabilitation group: During the study period of 8 weeks, all the study subjects participated 3 exercise sessions last 60-90 minutes, per week. The subjects in this group followed routine rehabilitation unit protocol that was 20 min warm up, 25–60 min aerobic, resistance and flexibility exercise on machines (e.g., treadmill, stationary bike, stepper, AB King Pro) at an intensity of 11–13 on the Borg scale and 10 min cool down. Intervention 3: control group: the control group was only followed-up and during this period they did not experience any exercise.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Azam Moosavi Sohroforouzani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Physical Education &amp; Sport Science, University of Isfahan</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 31 5263 8240</telephone>
        <email>azamsadat_moosavi@yahoo.com</email>
        <affiliation>University of Isfahan</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Azam Moosavi Sohroforouzani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Physical Education &amp; Sport Science, University of Isfahan</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 31 5263 8240</telephone>
        <email>azamsadat_moosavi@yahoo.com</email>
        <affiliation>University of Isfahan</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: patients with coronary artery disease after coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI); 3 months after coronary artery bypass surgery or coronary angioplasty; Surgical repair in patients. Exclusion criteria: Any adverse conditions or obstacles that interfere exercise intervention and assess the effectiveness of the training program is difficult; Diseases such as uncontrolled hypertension, arthritis, respiratory diseases, acute orthopedic problems and musculoskeletal pain were included; regular exercise Before entering the study.</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>68 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I25.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Atherosclerotic heart disease</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Home-based exercise rehabilitation group: The subjects in this group participated in aerobic and resistance exercise at home for 8 weeks, 3 sessions per week about 60-90 minutes. The Home-based exercise program includes 10 min warm up, 5 min aerobic exercise, 5 min resistance exercise, 25–60 min brisk walking or jogging at an intensity of 11–13 on the Borg scale and 10 min cool down.</i_keyword>
      <i_keyword>Centre-based cardiac rehabilitation group: During the study period of 8 weeks, all the study subjects participated 3 exercise sessions last 60-90 minutes, per week. The subjects in this group followed routine rehabilitation unit protocol that was 20 min warm up, 25–60 min aerobic, resistance and flexibility exercise on machines (e.g., treadmill, stationary bike, stepper, AB King Pro) at an intensity of 11–13 on the Borg scale and 10 min cool down.</i_keyword>
      <i_keyword>control group: the control group was only followed-up and during this period they did not experience any exercise</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>LDH. Timepoint: The bigining and the end of the intervention. Method of measurement: U/L, Laboratory measurements.</prim_outcome>
      <prim_outcome>SGOT. Timepoint: The bigining and the end of the intervention. Method of measurement: U/L, Laboratory measurements.</prim_outcome>
      <prim_outcome>SGPT. Timepoint: The bigining and the end of the intervention. Method of measurement: U/L, Laboratory measurements.</prim_outcome>
      <prim_outcome>ALK. Timepoint: The bigining and the end of the intervention. Method of measurement: U/L, Laboratory measurements.</prim_outcome>
      <prim_outcome>HDL. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/dl, Laboratory measurements.</prim_outcome>
      <prim_outcome>FBS. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/dl, Laboratory measurements.</prim_outcome>
      <prim_outcome>CBC. Timepoint: The bigining and the end of the intervention. Method of measurement: Laboratory measurements.</prim_outcome>
      <prim_outcome>LDL. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/dl, Laboratory measurements.</prim_outcome>
      <prim_outcome>Cholesterol. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/dl, Laboratory measurements.</prim_outcome>
      <prim_outcome>Triglyceride. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/dl, Laboratory measurements.</prim_outcome>
      <prim_outcome>Quality of life. Timepoint: The bigining and the end of the intervention. Method of measurement: Questionnaire SF36.</prim_outcome>
      <prim_outcome>Anxiety. Timepoint: The bigining and the end of the intervention. Method of measurement: Questionnaire S.A.S.</prim_outcome>
      <prim_outcome>Depretion. Timepoint: The bigining and the end of the intervention. Method of measurement: Questionnaire Beck.</prim_outcome>
      <prim_outcome>Type A behavior. Timepoint: The bigining and the end of the intervention. Method of measurement: Questionnaire TAB.</prim_outcome>
      <prim_outcome>Systolic blood pressure. Timepoint: The bigining and the end of the intervention. Method of measurement: Mercury sphygmomanometer, mmHg.</prim_outcome>
      <prim_outcome>Diastolic blood pressure. Timepoint: The bigining and the end of the intervention. Method of measurement: Mercury sphygmomanometer, mmHg.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of Isfahan, Faculty of Physical Education &amp; Sport Science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2013-11-22</approval_date>
        <contact_name>Isfahan Cardiovascular Research Institute</contact_name>
        <contact_address>Isfahan Cardiovascular Research Institute, Khoram Avenue Isfahan  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
